QA: IDEAYA Biosciences Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001676725_2023_IDEAYA_Biosciences_Inc.pdf

Logs

Graph

Absolute values for 0001676725, IDEAYA Biosciences Inc.

  xvar xval
0 AssetsCurrent 370,454,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,509,000
3 remainder_Assets 11,006,000
4 LiabilitiesCurrent 31,718,000
5 LiabilitiesNoncurrent 6,796,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 23,897,000
9 ResearchAndDevelopmentExpense 89,536,000
10 remainder_Expenses 0
11 remainder_Revenues 50,931,000
12 remainder_NetIncome 3,847,000
13 remainder_ComprehensiveNetIncome -2,159,000
  yvar yval
0 Assets 387,969,000
1 Liabilities 38,514,000
2 Expenses 113,433,000
3 Revenues 50,931,000
4 StockholdersEquity 349,455,000
5 NetIncome -58,655,000
6 ComprehensiveNetIncome -59,734,500
7 BaseVar 298,426,500
8 EconomicCapitalRatio 2.54

Edgar->Model Mapping

Feature Distribution

Change over Time